Mangalam Drugs and Organics Ltd.

NSE: MANGALAM | BSE: 532637 | ISIN: INE584F01014 | Industry: Pharmaceuticals
|
27.1900 0.18 (0.67%)
NSE Aug 07, 2026 15:31 PM
Volume: 23,709
 

ICICI Securities Limited
Mangalam Drugs & Organics (Mangalam) is one of the largest and most preferred API suppliers for anti-malarial drug manufacturing companies in India and abroad. It is one of the five companies globally to qualify under the Bill Clinton Foundation for supply of anti-malarial drugs. The company's APIs are largely supplied to companies, which participate in WHO tenders and are funded by various global agencies like Clinton Foundation, Gates...
Mangalam Drugs has lost -23.92% in the last 6 Months
More from Mangalam Drugs and Organics Ltd.
Recommended